This project investigates the impact of selective serotonin reuptake inhibitors (SSRIs) on sleep and dreaming in individuals with Major Depressive Disorder (MDD). Using a longitudinal design, high-density EEG, polysomnography, and serial awakening methods, the study aims to quantify changes in dream frequency, intensity, and neurophysiology before and after SSRI treatment. The findings will enhance understanding of how antidepressants influence sleep-related emotional processing, with potential implications for optimizing treatment strategies and improving patient outcomes in MDD.